These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3885394)

  • 21. Fluorometric and flow cytometric analysis of the cyclosporine-calmodulin interaction in T lymphocytes.
    Colombani PM; Hess AD
    Methods Enzymol; 1987; 139():677-90. PubMed ID: 3495716
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of cyclosporine binding by cyclophilin and calmodulin and the identification of a novel 45 KD cyclosporine-binding phosphoprotein in Jurkat cells.
    Foxwell BM; Hiestand PC; Wenger R; Ryffel B
    Transplantation; 1988 Aug; 46(2 Suppl):35S-40S. PubMed ID: 3043797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of cyclosporin action: in vitro studies.
    Ryffel B
    Ann Inst Pasteur Immunol; 1987; 138(4):635-9. PubMed ID: 3499916
    [No Abstract]   [Full Text] [Related]  

  • 25. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae.
    Tropschug M; Barthelmess IB; Neupert W
    Nature; 1989 Dec 21-28; 342(6252):953-5. PubMed ID: 2531848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophilin B mediates cyclosporin A incorporation in human blood T-lymphocytes through the specific binding of complexed drug to the cell surface.
    Allain F; Denys A; Spik G
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):565-70. PubMed ID: 8713086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of ciclosporin immunosuppression.
    Lorber MI
    Year Immunol; 1989; 4():253-63. PubMed ID: 2648704
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation--a comparative analysis in vitro.
    Baumann G; Andersen E; Quesniaux V; Eberle MK
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):43-8. PubMed ID: 1496687
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.
    el Rouby S; Shi Y; Reem GH
    Clin Exp Immunol; 1992 Jul; 89(1):136-42. PubMed ID: 1628422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.
    Maki N; Sekiguchi F; Nishimaki J; Miwa K; Hayano T; Takahashi N; Suzuki M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5440-3. PubMed ID: 1695378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy.
    Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD
    Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens.
    Kroczek RA; Black CD; Barbet J; Shevach EM
    J Immunol; 1987 Dec; 139(11):3597-603. PubMed ID: 3119712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
    Palacios R
    J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 36. The interaction of cyclosporin and calmodulin.
    Steiner RF; Albaugh S
    Biopolymers; 1990; 29(6-7):1005-14. PubMed ID: 2369611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the immunosuppressive effects of cyclosporine, lipid-soluble anesthetics, and calmodulin antagonists. Response to exogenous interleukin 2.
    LeGrue SJ; Munn CG
    Transplantation; 1986 Dec; 42(6):679-85. PubMed ID: 3097893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation.
    Emmel EA; Verweij CL; Durand DB; Higgins KM; Lacy E; Crabtree GR
    Science; 1989 Dec; 246(4937):1617-20. PubMed ID: 2595372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
    Colombani PM; Bright EC; Monastyrskyj O; Hess AD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1171-4. PubMed ID: 2950628
    [No Abstract]   [Full Text] [Related]  

  • 40. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.